Ask AI
Biomarker Testing: Prostate Cancer

CE / CME

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Prostate Cancer

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Released: March 25, 2026

Expiration: September 24, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which of the following should you recommend for all patients with high-risk localized early prostate cancer to help inform them about their cancer and potential prognosis and treatment implications?

2.

I am very confident in my ability to identify actionable biomarkers in patients with prostate cancer following guideline-recommendations (ie, BRCA1/2, HRR, MSI, HER2, and PSMA status) and to facilitate patient education and shared decision-making.